Ranokhon Igamberdieva
- Soʻnggi maʼlum muassasa:
- Toshkent davlat tibbiyot universiteti
- ORCID:
- 0000-0002-7314-0309
0
h-indeks
0
i10-indeksi
0
Iqtiboslar
30
Asarlar
Vaqt boʻyicha
Vaqt boʻyicha tahlil
Iqtibos sharhi
Yillar boʻyicha nashrlar (ustun) va iqtiboslar (chiziq)
- Nashrlar
- Iqtiboslar
Nashr tarixi
h-indeks evolyutsiyasi
Yillar boʻyicha jamlangan h-indeks
Eng koʻp iqtibos qilingan asarlar
- P0213CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION: RISK OF COMPLICATIONS20200 iqtibos
- Epidemiological, clinical and morphological aspects of kidney damage in COVID-1920210 iqtibos
- MO123USE OF RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND ADVANCED CHRONIC KIDNEY DISEASE*20210 iqtibos
- POS-358 ANTICOAGULANT THERAPY FOR CHRONIC KIDNEY DISEASE IN COMBINATION WITH ATRIAL FIBRILLATION20210 iqtibos
- MO184ANTICOAGULANT THERAPY IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION20210 iqtibos
- MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF20220 iqtibos
- POS-246 EVALUATION OF THE USE OF RIVAROXABAN IN PATIENTS WITH STAGE 4 CKD IN AF20220 iqtibos
- POS-320 EFFECTIVENESS AND SAFETY OF RIVAROXABAN VERSUS WARFARIN IN NONVALVULAR ATRIAL FIBRILLATION PATIENTS WITH OBESITY, TYPE TWO DIABETES AND CKD20220 iqtibos
- MO638: Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Obesity, Type Two Diabetes, CKD20220 iqtibos
- MO162: Renal Function During Long-Term Use of Oral Anticoagulants in Patients with Atrial Fibrillation20220 iqtibos
Hammualliflar
- Sherzod Abdullaev28 ta umumiy asar2020–2026
- Olimkhon Sharapov6 ta umumiy asar2021–2025
- Музаффар Илхомжон Асомов3 ta umumiy asar2025
- Rakhimjon Tursunbayev2 ta umumiy asar2025
- Sherzod Abdullaev1 ta umumiy asar2025
- Gulchehra Atakhodjayeva1 ta umumiy asar2025
- Saodat Ulmasova1 ta umumiy asar2025
- Batir Daminov1 ta umumiy asar2021